Anti-NMDA receptor encephalitis: Difference between revisions
(Blanked the page) |
No edit summary |
||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Anti-NMDA receptor encephalitis}} | |||
'''For patient information, click [[Anti-NMDA receptor encephalitis (patient information)|here]].''' | |||
{{CMG}} AE {{DMakkar}} | |||
{{SK}} | |||
== [[Anti-NMDA receptor encephalitis overview|Overview]] == | |||
== [[Anti-NMDA receptor encephalitis historical perspective|Historical Perspective]] == | |||
== [[Anti-NMDA receptor encephalitis pathophysiology|Pathophysiology]] == | |||
__NOTOC__ | |||
{{CMG}} AE {{DMakkar}} | |||
== [[Anti-NMDA receptor encephalitis causes|Causes]] == | |||
== [[Differentiating Anti-NMDA receptor encephalitis from other diseases|Differentiating Anti-NMDA receptor encephalitis from other Diseases]] == | |||
== [[Anti-NMDA receptor encephalitis epidemiology and demographics|Epidemiology and Demographics]] == | |||
== [[Anti-NMDA receptor encephalitis risk factors|Risk Factors]] == | |||
== [[Anti-NMDA receptor encephalitis natural history, complications and prognosis|Natural History, Complications and Prognosis]] == | |||
== Diagnosis == | |||
[[Anti-NMDA receptor encephalitis history and symptoms|History and Symptoms]] | [[Anti-NMDA receptor encephalitis physical examination|Physical Examination]] | [[Anti-NMDA receptor encephalitis laboratory findings|Laboratory Findings]] | [[Anti-NMDA receptor encephalitis CT|CT]] | [[Anti-NMDA receptor encephalitis MRI|MRI]] | [[Anti-NMDA receptor encephalitis other diagnostic studies|Other Diagnostic Studies]] | |||
== Treatment == | |||
[[Anti-NMDA receptor encephalitis medical therapy|Medical Therapy]] | [[Anti-NMDA receptor encephalitis primary prevention|Primary Prevention]] | [[Anti-NMDA receptor encephalitis secondary prevention|Secondary Prevention]] | [[Anti-NMDA receptor encephalitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Anti-NMDA receptor encephalitis future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Anti-NMDA receptor encephalitis case study one|Case #1]] | |||
==Related Chapters== | |||
== Acknowledgements == | |||
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D. | |||
{{WH}} | |||
{{WikiDoc Sources}} | |||
[[Category:Disease]] | |||
[[Category:Neurology]] | |||
[[Category:Viral diseases]] | |||
Latest revision as of 21:04, 13 May 2023
|
Anti-NMDA receptor encephalitis Microchapters |
|
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anti-NMDA receptor encephalitis On the Web |
|
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis |
|
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
|
Risk calculators and risk factors for Anti-NMDA receptor encephalitis |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] AE Dheeraj Makkar, M.D.[2]
Synonyms and keywords:
Overview
Historical Perspective
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3] AE Dheeraj Makkar, M.D.[4]
Causes
Differentiating Anti-NMDA receptor encephalitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.